跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 1,368 条关于
“MESI”
全部
1,368
临床试验
1,102
药物
191
机构
15
资讯
60
去年
Kodiak Sciences' KSI-101 Demonstrates 62% Vision Improvement in Phase 1b MESI Trial
7个月前
Kodiak Sciences to Present Final Phase 1b Results for KSI-101 in Macular Edema Secondary to Inflammation
上个月
Kodiak Sciences Completes Enrollment in First Pivotal Cohort of Phase 3 PEAK Trial for KSI-101 in Macular Edema Secondary to Inflammation
去年
Kodiak Sciences' Tarcocimab Shows Promise in Phase 3 Retinal Disease Trials, Analyst Upgrades Stock
去年
China Launches Major Trial Testing Nafamostat Mesilate for Sepsis Treatment Across 32 Hospitals
5个月前
UCB Acquires Neurona Therapeutics for $1.15 Billion to Advance Regenerative Cell Therapy for Drug-Resistant Epilepsy
去年
uniQure Doses First Patient in Phase I/IIa Trial of AMT-260 for Refractory Mesial Temporal Lobe Epilepsy
去年
uniQure Doses First Patient in Phase I/IIa Trial of AMT-260 for Refractory Mesial Temporal Lobe Epilepsy
去年
uniQure's Gene Therapy AMT-260 Achieves 92% Seizure Reduction in First Drug-Resistant Epilepsy Patient
去年
China's NMPA Accepts NDAs for Lung and Liver Cancer Therapies
第 1 页,共 6 页
上一页
下一页